Barinthus Biotherapeutics. (BRNS) Q2 2023 Earnings

10AugExpected
Q2 2023
-0.62
-0.6
-0.57
-0.55

Details

Expected EPS
-0.55
Actual EPS
-0.62
Surprise EPS
-0.07
Surprise Percent
+12.73%

Description

Barinthus Biotherapeutics. (BRNS) has reported earnings of -0.62 per share for Q2 2023.

0 Comments

Share your thoughts